Health Diagnostics

BioMedomics - BioMedomics develops advanced quantitative point-of-care (POC) diagnostic platforms and disease-specific diagnostic tests.

Livo.ai - Re-envisioning blood diagnostics, making it accessible, affordable and accurate.

Relitect - Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.

CryoLogyx - CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery.

DxUpClose - DxUpClose develops a point-of-care bacterial diagnostic that performs an antibiotic sensitivity test in 60 minutes.

Glycominds - Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.

BioMarCare Technologies - BioMarCare Technologies develops tumor biomarkers for the early detection, prognosis, and monitoring of cancer.

Acumen Pharmaceuticals - Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

Inspiration Biopharmaceuticals - Inspiration Biopharmaceuticals develops recombinant blood coagulation factor products for the treatment of hemophilia.

Personal Genome Diagnostics - Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies.

© 2025 bioDAO.ai